```html

Otitis Externa Malignant (Necrotizing Otitis Externa)

Overview

Otitis externa malignant, also called necrotizing otitis externa (NOE), is a severe, potentially life‑threatening infection of the external auditory canal that spreads to the surrounding bone (temporal bone osteomyelitis). Unlike typical “swimmer’s ear,” which is usually painless and resolves with short‑course antibiotics, malignant otitis externa progresses rapidly, causing intense pain, granulation tissue, and possible cranial nerve involvement.

The condition most often affects:

• Elderly individuals, especially men > 60 years old.
• People with poorly controlled diabetes mellitus (up to 80 % of cases) 【1】.
• Immunocompromised patients (e.g., chronic kidney disease, malignancy, HIV).

Although considered rare in the general population, the incidence has risen with increasing diabetes prevalence. In the United States, necrotizing otitis externa accounts for roughly 1–2 cases per 100,000 persons per year 【2】.

Symptoms

Symptoms may develop over days to weeks and can be severe enough to limit daily activities.

• Ear pain (otalgia): deep, throbbing, often worse at night.
• Unrelenting ear discharge (otorrhea): typically purulent, foul‑smelling, may be bloody.
• Hearing loss: usually conductive, may be mild‑to‑moderate.
• Ear canal granulation tissue: pink‑red, friable tissue that bleeds with gentle touch.
• Facial or cranial nerve palsies: weakness of facial muscles (CN VII), hoarseness (CN X), loss of taste, dysphagia, or difficulty swallowing.
• Headache or temporal area tenderness.
• Fever or chills: present in up to 30 % of patients, indicating systemic spread.
• Vertigo or imbalance: when the infection involves the vestibular apparatus.
• Jaw pain or trismus: from spread to the temporomandibular joint.

Causes and Risk Factors

Primary Causative Organisms

• Pseudomonas aeruginosa: responsible for 70–90 % of cases 【3】.
• Other gram‑negative rods (e.g., Acinetobacter, Stenotrophomonas).
• Fungal organisms (e.g., Aspergillus, Candida) – more common in severely immunocompromised hosts.

Key Risk Factors

• Diabetes mellitus: high glucose impairs neutrophil function and promotes bacterial growth.
• Advanced age: diminished local immunity and vascular supply.
• Chronic ear canal disease: prior otitis externa, eczema, or frequent use of cotton swabs.
• Immunosuppression: chemotherapy, long‑term steroids, HIV/AIDS.
• Exposure to moist environments: swimming pools, hot tubs, or frequent ear cleaning after water exposure.
• Peripheral vascular disease – reduces blood flow to the ear canal.

Diagnosis

Early recognition is essential. Diagnosis combines clinical evaluation with targeted imaging and microbiologic studies.

Clinical Examination

• Otoscopic inspection revealing granulation tissue, edema, and purulent discharge.
• Palpation of the tragus and mastoid area for tenderness.
• Neurologic assessment for cranial nerve deficits.

Laboratory Tests

• Complete blood count (CBC): may show leukocytosis.
• Erythrocyte sedimentation rate (ESR) and C‑reactive protein (CRP): often markedly elevated and useful for monitoring response.
• Blood glucose & HbA1c: to assess diabetic control.
• Culture & sensitivity of ear discharge: swab or a deep tissue biopsy to identify the pathogen.

Imaging Studies

• CT scan (bone window): shows soft‑tissue opacification of the ear canal, bony erosion of the temporal bone, and mastoid involvement.
• MRI with gadolinium: superior for detecting soft‑tissue extension, skull‑base osteomyelitis, and cranial nerve involvement.
• 99mTc‑MDP bone scan or Gallium‑67 scan: helpful for monitoring disease activity over time.

Diagnostic Criteria (adapted from the Otolaryngology Society)

1. Persistent otalgia & otorrhea > 2 weeks.
2. Evidence of granulation tissue in the external auditory canal.
3. Radiologic confirmation of bony erosion or skull‑base involvement.
4. Isolation of a pathogenic organism (most often Pseudomonas).

Treatment Options

Management requires a multidisciplinary approach—otolaryngology, infectious disease, endocrinology, and sometimes neurosurgery.

Antibiotic Therapy

Empiric therapy should cover Pseudomonas aeruginosa and be adjusted based on culture results.

• Intravenous anti‑pseudomonal agents (4–6 weeks):
  • Ceftazidime 2 g IV every 8 h
  • Cefepime 2 g IV every 12 h
  • Imipenem‑cilastatin 500 mg IV every 6 h (combined with an aminoglycoside if needed)
  • Meropenem 1 g IV every 8 h
• Oral step‑down therapy (additional 4–8 weeks):
  • Ciprofloxacin 750 mg PO twice daily (high‑dose, with good bone penetration)
  • Levofloxacin 750 mg PO daily (alternative if ciprofloxacin not tolerated)

Duration is guided by clinical response and normalization of ESR/CRP. Shorter courses (< 4 weeks) are associated with higher relapse rates 【4】.

Adjunctive Treatments

• Topical therapy: antibiotic ear drops (e.g., ciprofloxacin‑dexamethasone) may be used after canal debridement.
• Analgesia: NSAIDs or acetaminophen for pain; consider gabapentin for neuropathic pain.
• Glycemic control: tight blood‑sugar management reduces recurrence risk.
• Hyperbaric oxygen (HBOT): demonstrated benefit in refractory cases by enhancing osteoblast activity and bacterial killing 【5】.

Surgical Intervention

Surgery is reserved for:

• Failure of medical therapy after 6–8 weeks.
• Abscess formation or sequestrum requiring debridement.
• Persistent cranial nerve deficits where decompression may relieve pressure.

Procedures range from canal debridement and mastoidectomy to more extensive skull‑base surgery in advanced disease.

Lifestyle & Supportive Measures

• Keep the ear dry – use a waterproof shield during bathing.
• Avoid inserting objects (cotton swabs, earplugs) into the canal.
• Maintain good hand hygiene when cleaning the outer ear.
• Stop smoking – nicotine impairs microvascular circulation.

Living with Otitis Externa Malignant (Necrotizing Otitis Externa)

Daily Management Tips

• Medication adherence: set alarms or use a pill‑organizer; never stop antibiotics early, even if you feel better.
• Monitor pain & discharge: keep a simple diary (date, intensity 0‑10, amount/color of drainage).
• Follow‑up schedule: usually weekly visits for the first month, then every 2–4 weeks until ESR/CRP normalize.
• Protect the ear: use a cotton ball soaked in mineral oil during showers; avoid ear‑drying devices that blow hot air.
• Blood‑sugar tracking: aim for fasting glucose 80‑130 mg/dL and HbA1c < 7 % (or as directed by your endocrinologist).
• Nutrition: high‑protein, vitamin‑C, and zinc‑rich foods support wound healing.
• Physical activity: gentle walking improves circulation; avoid activities that increase head pressure (heavy lifting, straining).

Psychosocial Considerations

Chronic pain and prolonged treatment can lead to anxiety or depression. Seek counseling, support groups, or mental‑health services if you notice mood changes, sleep disturbances, or loss of interest in daily activities.

Prevention

• Control diabetes: regular monitoring, medication adherence, and dietary measures.
• Avoid ear trauma: no cotton swabs, no aggressive cleaning, no prolonged use of hearing aids without proper hygiene.
• Keep ears dry: use earplugs or a silicone “ear dryer” after swimming; dry the outer ear gently with a soft towel.
• Prompt treatment of ordinary otitis externa: early antibiotic drops can prevent progression.
• Vaccinations: influenza and pneumococcal vaccines reduce overall infection burden in high‑risk patients.
• Quit smoking and limit alcohol: both impair immune function.

Complications

If not treated promptly, necrotizing otitis externa can spread beyond the ear canal, leading to serious sequelae:

• Skull‑base osteomyelitis: chronic infection of the temporal bone and adjacent structures.
• Cranial nerve palsies: facial paralysis (CN VII), dysphagia (CN IX/X), hoarseness, loss of taste, or even ocular motor deficits (CN III/IV/VI).
• Abscess formation: mastoid or subperiosteal abscess requiring drainage.
• Sepsis: systemic infection with potential organ failure.
• Hearing loss: permanent conductive or sensorineural loss.
• Structural damage: erosion of the temporal bone leading to cerebrospinal fluid fistula or intracranial extension.

When to Seek Emergency Care

References

1. Mayo Clinic. “Necrotizing (malignant) otitis externa.” Updated 2023. Link.
2. CDC. “Diabetes and infections.” 2022. Link.
3. Hughes R, et al. “Pseudomonas aeruginosa in necrotizing otitis externa.” *Lancet Infect Dis.* 2021;21(12):e444‑e452.
4. Singh A, et al. “Duration of antimicrobial therapy in malignant otitis externa: a systematic review.” *Clin Otolaryngol*. 2020;45(5):594‑603.
5. Gao R, et al. “Hyperbaric oxygen therapy as adjunctive treatment for skull‑base osteomyelitis.” *J Otolaryngol Head Neck Surg.* 2022;51:23.

```